https://biomunex.screenup.com/ https://biomunex.screenup.com/biomunex-pharmaceuticals-societe-specialisee-dans-le-traitement-du-cancer-presente-de-nouvelles-donnees-precliniques-sur-son-approche-proprietaire-de-redirection-des-cellules-mait-a-laacr1-2024/ 2025-09-25T10:13:01+02:00 https://biomunex.screenup.com/biomunex-nomme-son-nouveau-conseil-scientifique-dedie-aux-mait-constitue-dexperts-mondiaux-des-cellules-mait-afin-daccelerer-le-developpement-de-ses-mait-engagers-en-immuno-oncolog/ 2025-09-24T18:04:08+02:00 https://biomunex.screenup.com/biomunex-appoints-its-new-sceitnficie-advisory-board-on-mait-composed-of-mait-cells-experts-to-accelerate-the-development-of-its-mait-engagers-in-immune-oncology/ 2025-09-24T18:04:04+02:00 https://biomunex.screenup.com/biomunex-et-le-laboratoire-ipsen-annoncent-un-accord-de-licence-mondial-exclusif-pour-un-activateur-de-cellules-mait-une-nouvelle-classe-therapeutique-en-immuno-oncologie/ 2025-09-24T18:03:58+02:00 https://biomunex.screenup.com/biomunex-and-ipsen-announce-exclusive-global-licensing-agreement-for-first-in-class-mait-cell-engager-in-immune-oncology/ 2025-09-24T18:03:54+02:00